Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Phytocannabinoids, particularly cannabidiol (CBD), have been studied for their potential effects on the muscles, especially in the context of muscle pain, spasms, and recovery. The main scientific rationale for their use comes from their interaction with the endocannabinoid system (ECS), which plays a role in pain modulation, inflammation, and muscle tone. Some studies suggest that CBD may help reduce inflammation and muscle soreness following intense exercise, and there is evidence supporting the use of cannabinoids for muscle spasticity, particularly in conditions like multiple sclerosis. For example, nabiximols (a cannabis-derived oromucosal spray containing both THC and CBD) is approved in several countries for treating spasticity in multiple sclerosis, demonstrating a clinically validated effect on muscle-related symptoms. However, evidence for general muscle health or athletic recovery in healthy individuals is still limited, with most studies being small, short-term, or preclinical. Traditional use of cannabis preparations for muscle pain and relaxation exists, but the current justification is primarily based on emerging scientific evidence, especially in specific medical contexts. More large-scale, high-quality trials are needed to fully establish efficacy and safety for broad muscle support applications.

More about Phytocannabinoid (unspecified)
More about Muscles

Other ingredients that support Muscles

Other body systems supported by Phytocannabinoid (unspecified)

Products containing Phytocannabinoid (unspecified)